table 1 : World Health organisation criterion for the diagnosis of osteoporosis, 1994 category definition by bone mineral density t-score Normal A value for BMD that is not more than 1 SD below the young adult mean value ≥-1 Osteopenia A value for BMD that lies between 1 and 2.5 SD below the young adult mean value -1 to -2.5 Osteoporosis A value for BMD that is more than 2.5 SD below the young ...

Osteoporosis is a growing health concern worldwide and its complications are as prevalent as other common chronic disease complications such as hypertension and diabetes. In this review, we will discuss the role of gender in osteoporosis, especially related to peak bone mass and maturation, rate of annual bone loss, screening, prevalence of osteoporosis and its related fractures, mortality afte...

Osteoporosis is a serious public health issue and a major cause of bone fracture worldwide. These fractures are associated with major risk of morbidity such as chronic pain or long term disability, early mortality and higher healthcare costs [1]. Three important issues are in the way of the management of osteoporosis. First is population awareness regarding osteoporosis prevention and self-mana...

This prospective intervention study was undertaken to estimate the prevalence and treatment rate of osteoporosis following osteoporosis screening tests in the same cohort. From November 1, 2014 to August 31, 2015, participants received screening tests for osteoporosis using ultrasound bone densitometry and education concerning osteoporosis and related conditions. The participants were interview...

Objective: The aim of this review of the literature is to report the factors which both contribute to the frailty syndrome and increase hip fracture risk in the elderly. This work is the fruit of common reflection by geriatricians, endocrinologists, gynecologists and rheumatologists, and seeks to stress the importance of detection and management of the various components of frailty in elderly s...

OBJECTIVE (1) To identify patients at risk for osteoporosis through community pharmacy-based bone mineral density (BMD) screening, to refer at-risk patients to primary care and/or specialty practice physicians, and to follow-up with at-risk patients; (2) to treat and manage osteopenic and osteoporotic patients referred to the pharmacy for medication therapy management services; and (3) to test ...